Copperwynd Financial LLC Increases Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Copperwynd Financial LLC increased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 55.0% in the 2nd quarter, Holdings Channel.com reports. The fund owned 30,949 shares of the pharmacy operator’s stock after acquiring an additional 10,982 shares during the quarter. Copperwynd Financial LLC’s holdings in Walgreens Boots Alliance were worth $367,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. Ascent Group LLC acquired a new position in shares of Walgreens Boots Alliance during the 2nd quarter worth about $133,000. Bontempo Ohly Capital Mgmt LLC raised its holdings in shares of Walgreens Boots Alliance by 1.6% during the second quarter. Bontempo Ohly Capital Mgmt LLC now owns 166,556 shares of the pharmacy operator’s stock valued at $2,014,000 after acquiring an additional 2,580 shares during the last quarter. Straight Path Wealth Management lifted its position in shares of Walgreens Boots Alliance by 2.8% in the second quarter. Straight Path Wealth Management now owns 54,500 shares of the pharmacy operator’s stock valued at $659,000 after acquiring an additional 1,500 shares in the last quarter. Scientech Research LLC acquired a new stake in shares of Walgreens Boots Alliance in the second quarter worth approximately $1,215,000. Finally, The Manufacturers Life Insurance Company increased its position in shares of Walgreens Boots Alliance by 2.1% during the second quarter. The Manufacturers Life Insurance Company now owns 436,849 shares of the pharmacy operator’s stock worth $5,284,000 after purchasing an additional 8,973 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Performance

Shares of Walgreens Boots Alliance stock opened at $9.06 on Friday. The firm has a market cap of $7.82 billion, a PE ratio of -1.34, a price-to-earnings-growth ratio of 0.97 and a beta of 0.70. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance, Inc. has a 52 week low of $8.22 and a 52 week high of $27.05. The business’s fifty day simple moving average is $10.00 and its 200-day simple moving average is $14.28.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). The company had revenue of $36.40 billion for the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period last year, the business earned $1.00 EPS. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were given a dividend of $0.25 per share. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.04%. Walgreens Boots Alliance’s payout ratio is currently -14.84%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Truist Financial decreased their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a report on Friday, June 28th. UBS Group lowered their price target on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 3rd. JPMorgan Chase & Co. cut their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Bank of America lowered their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday, September 4th. Finally, TD Cowen cut their price target on Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a report on Thursday, September 12th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $14.73.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.